The offering structure grants underwriters a 45-day window to purchase an additional 4.5 million units to address potential over-allotments. Alongside the public offering, a sponsor has committed to a private placement of 350,000 units, contributing $3.5 million to the total capital raise. This brings the expected gross proceeds to $303.5 million, with the potential to reach $348.5 million if the over-allotment option is fully exercised.

Each unit sold in the IPO comprises one Class A ordinary share and one-tenth of a warrant, with each full warrant exercisable at $11.50. The company plans to list its units on the Nasdaq Global Market under the ticker XIIIU. Once separated, the shares and warrants are slated to trade under the symbols XIII and XIIIW, respectively. Management intends to leverage its broad background across sectors—ranging from energy and chemicals to enterprise software and media—to secure a competitive acquisition deal.